A practical guide to robust detection of GABA in human brain by J-difference spectroscopy at 3 T using a standard volume coil.
gamma-Aminobutyric acid (GABA) is the major inhibitory neurotransmitter in human brain and has been implicated in several neuropsychiatric disorders. In vivo human brain GABA concentrations are near the detection limit for magnetic resonance spectroscopy ( approximately 1 mM), and because of overlap with more abundant compounds, spectral editing is generally necessary to detect GABA. In previous reports, GABA spectra edited by J-difference spectroscopy vary considerably in appearance. We have evaluated the factors that affect GABA spectra and the conditions necessary for robust acquisition of J-difference spectra from arbitrary brain regions. In particular, we demonstrate that variations in spectral quality can be explained in part by the incoherent addition of transients that results from shot to shot frequency and phase variations. An automated time-domain spectral alignment strategy that enables reproducible acquisition of high-quality GABA spectra at 3 T with a standard 30-cm T/R volume coil is presented. Representative GABA spectra from human frontal lobe, an area where susceptibility-induced frequency and phase variations are especially troublesome, that demonstrate the robustness of the acquisition and data handling strategy used in this study are presented.
Waddell
Kevin W
KW
Institute of Imaging Science, Vanderbilt University, Nashville, TN 37232-2675, USA. kevin.waddell@vanderbilt.edu
Avison
Malcolm J
MJ
Joers
James M
JM
Gore
John C
JC
D001923:Brain Chemistry; D006801:Humans; D009682:Magnetic Resonance Spectroscopy / Q000295:instrumentation / Q000379:methods*; D015203:Reproducibility of Results; D012815:Signal Processing, Computer-Assisted; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
D005680:gamma-Aminobutyric Acid
NMR Biomed. 2000 May;13(3):129-53
10861994
Biol Psychiatry. 2005 Jan 1;57(1):44-8
15607299
Crit Rev Neurobiol. 2000;14(1):23-45
11253954
Magn Reson Med. 2002 Mar;47(3):447-54
11870830
Mol Psychiatry. 2002;7 Suppl 1:S71-80
11986998
Magn Reson Med. 2002 May;47(5):1009-12
11979581
Magn Reson Med. 2002 Jun;47(6):1077-82
12111954
Magn Reson Med. 2003 Jul;50(1):19-23
12815674
Magn Reson Med. 2004 Jun;51(6):1115-21
15170830
Arch Gen Psychiatry. 2004 Jul;61(7):705-13
15237082
J Neurochem. 1979 Jun;32(6):1629-36
448355
Phys Med Biol. 1985 Apr;30(4):341-4
4001160
J Neurophysiol. 1989 Nov;62(5):1018-27
2573696
Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5662-6
8516315
Magn Reson Med. 1994 Sep;32(3):294-302
7984061
J Magn Reson B. 1995 Nov;109(2):169-74
7582599
Magn Reson Med. 1998 Jan;39(1):6-10
9438430
NMR Biomed. 1998 Oct;11(6):266-72
9802468
Magn Reson Med. 1999 Jan;41(1):35-42
10025609
Am J Psychiatry. 2004 Dec;161(12):2186-93
15569888
Magn Reson Med. 2001 Mar;45(3):517-20
11241712